What’s Driving Growth in the Stem Cell Manufacturing Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the stem cell manufacturing market right now?
The market size for stem cell manufacturing has seen a robust increase in recent years. Expected to surge from $17.5 billion in 2024 to $19.22 billion in 2025, it will achieve a compound annual growth rate (CAGR) of 9.8%. This striking growth in the historic period is credited to advancements in biotechnology, initiatives in research and development, clinical trials, and the progress in therapeutic applications. Additionally, the establishment of a regulatory framework and investments in infrastructure have also contributed to this growth.
How fast Is the stem cell manufacturing market expected to grow, and what’s its future value?
In the coming years, the stem cell manufacturing market is projected to experience a swift expansion. It’s estimated to reach $30.27 billion by 2029, with a compound annual growth rate (CAGR) of 12.0%. The forecasted growth is predominantly driven by factors such as increased funding and investments, the expanding applications in therapeutics, the advent of cell-based therapies, a rise in clinical trials and approvals, and the development of tailored therapies based on individual patients. Key trends to watch for during this forecast period include enhancement in 3D bioprinting, the proliferation of induced pluripotent stem cells (ipscs), the integration of automation and robotics, advancements in bioreactor technology, and efforts towards standardization and scalability.
Get your stem cell manufacturing market report here!
https://www.thebusinessresearchcompany.com/report/stem-cell-manufacturing-global-market-report
What are the leading drivers of growth in the stem cell manufacturing market?
The escalating numbers of older adults—those age 65 and above, known as the geriatric population—is anticipated to significantly stimulate the stem cell manufacturing market. This older demographic is often beset by an array of health conditions due to declining immunity and advancing age. The likelihood of developing chronic diseases also increases with age, and stem cell manufacturing could be key in combating these illnesses. For example, projections from the Population Reference Bureau, a nonprofit organization located in Kenya, indicate that the numbers of Americans in this age bracket will jump from 58 million in 2022 to 82 million by 2050—an impressive 47% rise. Similarly, it is predicted that this demographic will constitute an ever-growing percentage of the entire population—rising from 17% to 23% within the same span. Therefore, the surging numbers of older adults are fueling the expansion of the stem cell manufacturing market.
What are the key segments defining the stem cell manufacturing market?
The stem cell manufacturing market covered in this report is segmented –
1) By Product: Consumables, Instruments, Stem Cell Lines
2) By Application: Research Applications, Clinical Application, Cell And Tissue Banking Applications
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Institutes, Research Laboratories And Contract Research Organizations, Hospitals And Surgical Centers, Cell And Tissue Banks, Other End Users
Subsegments:
1) By Consumables: Media And Reagents, Cell Culture Vessels, Assay Kits
2) By Instruments: Bioreactors, Cell Counters, Flow Cytometers
3) By Stem Cell Lines: Embryonic Stem Cell Lines, Adult Stem Cell Lines, Induced Pluripotent Stem Cell Lines (iPSCs)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9402&type=smp
Who are the key players steering the development of the stem cell manufacturing market?
Major companies operating in the stem cell manufacturing market include Thermo Fisher Scientific Inc., Merck Millipore, Stemcell Technologies, Fujifilm Holdings Corporation, Takara Bio Group, Lonza Group AG, Sartorius AG, Bio-Rad Laboratories, Becton Dickinson and Company, Bio-Techne Corporation, Miltenyi Biotec, Terumo BCT Inc., Corning Inc., Eppendorf AG, ViaCyte Inc., Merck KGaA, Danaher Corporation, Vericel Corporation, American Cryostem Corporation, Cellgenix GMBH, Aspen Neuroscience Inc., Magenta Therapeutics Inc, Pluristem Therapeutics Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., 3D Biomatrix Inc., Worthington Biochemical Corporation, Bico Group
What emerging trends are influencing the growth of the stem cell manufacturing market?
The progression of technology plays a significant role within the stem cell manufacturing market trends. Industry participants are increasingly utilizing these advancements to maintain their market presence. For example, Bluebird Bio Inc., an American biotech company, announced in August 2022 that the U.S. Food and Drug Administration approved its ground-breaking one-time gene therapy, ZYNTEGLO, for patients needing regular red blood cell transfusions due to beta-thalassemia. A prominent feature of this treatment involves the ex-vivo method, in which a patient’s hematopoietic stem cells are integrated with a modified beta-globin gene, enabling normal hemoglobin production. ZYNTEGLO aims to achieve an independence from transfusions, consequently alleviating the medical challenges encountered by beta-thalassemia patients. The approval of this innovative therapy represents a pivotal moment in gene therapy, potentially offering a cure and heightening the quality of life for those impacted.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9402
Which regions are most influential in expanding the stem cell manufacturing market?
North America was the largest region in the stem cell manufacturing market in 2024. Europe was the second-largest region in the stem cell manufacturing market. The regions covered in the stem cell manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Monoclonal Antibodies (MAs) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/monoclonal-antibodies-global-market-report
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Neurology Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
